title: A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma.
authors.affiliation: Department of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Dahae
authors.initials: D
authors.lastname: Yang
authors.affiliation: Department of Laboratory Medicine, Ajou University School of Medicine, Suwon, Korea.
authors.forename: Sung Ran
authors.initials: SR
authors.lastname: Cho
authors.affiliation: Department of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Seri
authors.initials: S
authors.lastname: Jung
authors.affiliation: Department of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Woonhyoung
authors.initials: W
authors.lastname: Lee
authors.affiliation: Department of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Hyun Yong
authors.initials: HY
authors.lastname: Hwang
authors.affiliation: Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Ho Seop
authors.initials: HS
authors.lastname: Lee
authors.affiliation: Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
authors.forename: Yang Soo
authors.initials: YS
authors.lastname: Kim
authors.affiliation: Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Jong Rak
authors.initials: JR
authors.lastname: Choi
authors.affiliation: Department of Laboratory Medicine, Kosin University College of Medicine, Busan, Korea. mihakimp@hanmail.net.
authors.forename: Mi Hyang
authors.initials: MH
authors.lastname: Kim
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001854:Bone Marrow Cells / Q000166:cytology / Q000473:pathology; D005260:Female; D005434:Flow Cytometry; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016130:Immunophenotyping; D007938:Leukemia / Q000175:diagnosis* / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D010641:Phenotype; D000069283:Rituximab / Q000008:administration & dosage
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D000069283:Rituximab; D016044:Fusion Proteins, bcr-abl